Journal of Orthopedic Oncology
Open Access

Osteochondrodysplasias; Dysplasias; Hypoplasia

Introduction

Spondyloepiphyseal dysplasias (SED) affect the spine and long bones’ epiphyses, resulting in short stature, kyphosis (hunchback), and scoliosis (curvature of the spine). A chondroplasia is a form of shortlimbed dwarfism that involves the long bones’ growth plate. Metatropic dysplasia involves short stature and severe skeletal abnormalities, including spine curvature, scoliosis, and flattened vertebrae [1]. Thanatophoric dysplasia is a severe form of dwarfism that can cause respiratory failure and often leads to stillbirth or early death after birth.

Multiple epiphyseal dysplasia (MED) affects the growth of the epiphyses and can cause joint pain, stiffness, and osteoarthritis later in life. OCDs can also be classified based on the type of bone and cartilage defect present. These include: Chondrodysplasias, in which there is an abnormality of the cartilage tissue, resulting in improper bone formation. Osteodysplasias, in which there is an abnormality of the bone tissue itself. Metabolic bone disorders, in which there is a defect in the way the body processes minerals required for bone growth, such as calcium and phosphorus [2].

Results

The diagnosis of OCDs typically involves a combination of physical examination, imaging tests such as x-rays and CT scans, genetic testing, and family history. Treatment options vary depending on the extent and severity of the condition. In some cases, no treatment is necessary, and the individual can live a relatively normal life. In others, surgical intervention may be required to correct bone or joint deformities, while physical therapy can improve mobility and strength [3]. Currently, there is no cure for OCDs, and treatment is primarily supportive. However, ongoing research into genetic therapies, such as gene editing and stem cell treatments, may provide options for future treatments.

Osteochondrodysplasias are a group of genetic disorders that affect the growth and development of bones and cartilage. These conditions can result in short stature, joint deformities, and various other complications. While diagnosis can be complicated, treatment varies depending on the severity of the symptoms. Awareness of OCDs can lead to earlier detection, improved management, and better outcomes for affected individuals. Osteochondrodysplasia is a group of genetic disorders that affect growth and development of the skeleton. It is a rare condition and affects both humans and animals. The term osteochondrodysplasia is derived from three Greek words; osteon (bone), chondro (cartilage) and dysplasia (abnormal growth). Osteochondrodysplasia is often referred to as skeletal dysplasia or dwarfism [4].

The exact incidence of osteochondrodysplasia is unknown, but it is estimated to occur in approximately one in every 4,000 births. There are over 400 types of osteochondrodysplasia, each with different clinical features and severity. They can affect any part of the skeleton or all of it, and they may cause different types of abnormalities such as short stature, limb bowing, joint contractures, and other skeletal deformities. Osteochondrodysplasia is usually diagnosed during prenatal ultrasound or at birth if the baby is born with obvious physical abnormalities. Some people with milder forms of the condition may not be diagnosed until later in life [5]. Diagnosis is usually done by physical examination, x-rays, and genetic testing.

Discussion

The underlying genetic defect in osteochondrodysplasia may be autosomal dominant or autosomal recessive. Autosomal dominant means that the affected gene is located on one of the 22 pairs of nonsex chromosomes and a single copy of the mutated gene is enough to cause the condition. Autosomal recessive means that the affected gene is located on one of the 22 pairs of non-sex chromosomes, and two copies of the mutated gene are needed to cause the condition [6]. The most common form of osteochondrodysplasia is achondroplasia, which is an autosomal dominant disorder that affects about one in 15,000 to 40,000 live births. People with achondroplasia have short stature, shortened limbs, and other skeletal abnormalities. They also have a characteristic appearance, with a large head, prominent forehead, and midface hypoplasia. Achondroplasia is caused by a mutation in the FGFR3 gene, which encodes the fibroblast growth factor receptor 3 [7]. This receptor regulates bone growth by inhibiting the proliferation and differentiation of chondrocytes, the cells that form cartilage. When the receptor is mutated, it becomes overactive and suppresses bone growth and elongation, resulting in short stature [8].

Another type of osteochondrodysplasia is hypochondroplasia, which is a milder form of achondroplasia. Hypochondroplasia is also an autosomal dominant condition, but the mutations occur in a different part of the FGFR3 gene than those that cause achondroplasia. Hypochondroplasia has similar symptoms to achondroplasia but milder, including short stature and skeletal abnormalities [9].

Thanatophoric dysplasia is a severe form of Osteochondrodysplasia. It is caused by mutations in the FGFR3 gene like achondroplasia but in a different location. Thanatophoric dysplasia is a lethal condition that causes severe skeletal deformities, including limb shortening, narrow chest, and underdeveloped lungs. Infants with thanatophoric dysplasia usually die shortly after birth, and there is no cure. Spondyloepiphyseal dysplasia (SED) is another type of osteochondrodysplasia that affects the long bones and vertebrae. SED can be autosomal dominant or autosomal recessive [10]. People with SED have short stature, abnormal spinal curvature, and hip, knee, and ankle problems. They can also develop early-onset osteoarthritis due to the abnormal formation of joint cartilage.

Conclusion

Osteogenesis imperfecta (OI) is a genetic disorder that affects the collagen in bones, causing them to be brittle and easily fractured. OI is caused by mutations in the COL1A1 or COL1A2 gene, which encodes type I collagen. Collagen is the main protein in bone and provides strength and flexibility. People with OI have short stature and skeletal abnormalities, but also suffer from frequent fractures, hearing loss, and other complications. Treatment for osteochondrodysplasia is supportive and depends on the type and severity of the condition. Physical therapy can help improve mobility and stretching exercises can help prevent joint contractures. Some people may need braces or surgery to correct deformities or spinal curvature. Infants with severe forms of the condition may need medical interventions, such as assisted ventilation or surgery, to survive. Osteochondrodysplasia is a group of genetic disorders that affect the growth and development of the skeleton. It can cause a wide range of skeletal deformities, including short stature, limb bowing, and joint contractures. The underlying genetic defects can be autosomal dominant or autosomal recessive, and genetic testing is available to make a diagnosis. Treatment is supportive and depends.

1. Hudish LI, Reusch JE, Sussel L (2019) Β cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Investig 129: 4001-4008.

Indexed at, Google Scholar, Crossref

2. Jung CH, Son JW, Kang S, Kim WJ, Kim H, et al. (2021) Diabetes fact sheets in korea, 2020: An appraisal of current status. Diabetes Metab J 45: 1-10.

Indexed at, Google Scholar, Crossref

3. La Li J, Shangguan H, Chen X, Ye X, Zhong B, et al. (2020) Advanced glycation end product levels were correlated with inflammation and carotid atherosclerosis in type 2 diabetes patients. Open Life Sci  15: 364-372.

Indexed at, Google Scholar, Crossref

4. Choi H,  Koo D, Yim J (2022) Correlation of advanced glycation end products and heme oxygenase-1 in Korean diabetic patients. J Nutr Health 55: 348-358.

Google Scholar

5. https://europepmc.org/article/nbk/nbk537328.  
6. Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment.Foot Ankle 64-122.

Indexed at, Google Scholar, Crossref

7. Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation.Diabetes Care 21: 855-859.

Indexed at, Google Scholar, Crossref

8. Singer AJ, Tassiopoulos, Kirsner RS (2018) Evaluation and Management of Lower-Extremity Ulcers.N Engl J Med 378: 302-303.

Indexed at, Google Scholar, Crossref

9. Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic Foot Ulcers and Their Recurrence.N Engl J Med 376: 2367-2375.

Indexed at, Google Scholar, Crossref

10. Mutluoglu M, Uzun G, Turhan V, Gorenek L, Ay H, et al. (2012) How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers?J Diabetes Complications 26: 225-229.

Indexed at, Google Scholar, Crossref